The unique functional benefits of resistant starch continue to be uncovered
Release time:
2026-11-10
Two high‑profile studies have uncovered novel health benefits of resistant starch. A Zhejiang University study published in *Microbiome* compared three dietary fibers: microcrystalline cellulose, resistant starch and inulin. Resistant starch specifically enriches *Bifidobacterium pseudolongum*. Metabolite butyrate generated by this bacterium up‑regulates galectin‑4 to restore intestinal tight junctions and mucosal barrier, thereby alleviating colitis; synbiotic combination delivers enhanced protective effects. A joint clinical research from Peking University and Nanchang University, published in *Science*, demonstrates that a fiber blend of resistant starch, inulin and β‑glucan enriches *Bacteroides xylanisolvens*. It modulates hormone conversion, ameliorates hyperandrogenism and restores ovulation in patients with polyendocrine metabolic ovarian syndrome. These findings provide solid scientific support for dietary fiber applications in intestinal inflammation and endocrine‑metabolic health management.
The unique functional benefits of resistant starch continue to be uncovered
——Resistant starch alleviates colitis and modulates hormone conversion to improve polyendocrine metabolic ovarian syndrome
A study from Zhejiang University published in Microbiome systematically compared three classic dietary fibers, namely microcrystalline cellulose (MCC, non-fermentable), resistant starch (fermentable insoluble fiber) and inulin (fermentable soluble fiber), using a DSS-induced mouse colitis model. It ultimately identified a complete protective pathway: resistant starch specifically enriches Bifidobacterium pseudolongum. This bacterium ferments to produce butyrate, which upregulates galectin-4 (Lgals4) in intestinal epithelium to activate tight junction and cell proliferation pathways, thereby repairing the mucosal barrier and mitigating intestinal inflammation. A synbiotic regimen combining both delivers even more pronounced protective effects.

Head-to-head comparison of the three fibers: resistant starch exhibits the best anti-inflammatory and mucosal-repair efficacy In the experiment, cellulose in the standard chow was replaced with equal amounts of MCC, resistant starch (RS) and inulin respectively. After 5 weeks of feeding, acute colitis was induced via DSS, and protective effects were comprehensively compared from phenotypic to histological levels. Overall symptoms: RS confers the most remarkable anti-inflammatory effect
- Body weight and disease activity: All three fibers alleviated DSS-induced weight loss, diarrhea and bloody stools to varying degrees. Resistant starch showed the strongest effect with the largest reduction in disease activity index (DAI), followed by inulin, while microcrystalline cellulose had the weakest effect.
- Colon morphology: DSS causes colon shortening, tissue edema and ulceration. RS restored colon length to the greatest extent, improved crypt architecture and lowered histopathological scores.
Microbiome mechanism: Resistant starch specifically enriches Bifidobacterium pseudolongum
On November 5, 2026, a team led by Jie Qiao, Yanli Pang and Changtao Jiang from Peking University, together with Shaoping Nie from Nanchang University, published an article in Science (IF = 47.3) titled Targeting hormone conversion through dietary fiber improves polyendocrine metabolic ovarian syndrome. A 12-week clinical trial using a fiber blend consisting of inulin, resistant starch and β-glucan effectively ameliorated hyperandrogenism and restored ovulation in patients. Metagenomic sequencing revealed a key alteration: marked enrichment of Bacteroides xylanisolvens, whose abundance was negatively correlated with plasma androstenedione (A4) and testosterone (T) concentrations.

Quanyin Xiangyu (Beijing) Biotechnology Co., Ltd.
Address: A/ Beijing, B/Jnan Shandong
Working hours: Monday to Friday 9:00-18:00 GMT+8
Phone: +86-15911081400 (WeChat)
E-mail: Pekingxiangyu@gmail.com
Li (WeChat)
Li (WeChat)
copyright © 2023 Quanyin Xiangyu (Beijing) Biotechnology Co., Ltd. Powered by www.300.cn | TAGS